ABEMACICLIB | ABEMACICLIB : ATP competitive inhibitor of CDK4, CDK6
RATINGS:
Cellular Use: (2 reviews)

In Model Organisms: (2 reviews)
Control Compounds

Probe Summary

More...

Targets Biochemical/Biophysical Potency Cellular Potency
CDK4
  • IC50:2 nM
  • Ki:0.6 nM
  • IC50:120 nM
  • EC50:72 nM
  • IC50:60 nM
  • EC50:20 nM
  • IC50:90 nM
CDK6
  • IC50:10 nM
  • Ki:2.4 nM
    competitive ATP inhibitor
    up to 2 uM

    Selectivity

    In Vitro Selectivity Assessment
    Potency Assay Off-Target:
    Selectivity was evaluated in a panel of 100 protein kinases (Millipore/UBI). Profiled against 456 ki ...

    Potency
    Cellular
    In Vitro

    CDK4

    Mode of Action: competitive ATP inhibitor

    Structure-Activity-Relationship data available? Yes

    DOI Reference: 10.1007/s10637-014-0120-7

    CDK6

    Mode of Action: competitive ATP inhibitor

    Structure-Activity-Relationship data available? Yes

    DOI Reference: 10.1007/s10637-014-0120-7

    In Vivo Validations

    Mouse
    Dose: >12.5 mg/Kg
    Route of delivery: Oral

    DOI Reference: 10.1007/s10637-014-0120-7

    Orthogonal Probes def

    PALBOCICLIB
    CP-10

    Chemical Information

    Molecular Formula C27H32F2N8
    SMILEs CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1
    InChI InChI=1S/C27H32F2N8/c1-5-35-8-10-36(11-9-35)16-19-6-7-24(30-14-19)33-27-31-15-22(29)25(34-27)20-12-21(28)26-23(13-20)37(17(2)3)18(4)32-26/h6-7,12-15,17H,5,8-11,16H2,1-4H3,(H,30,31,33,34)
    Molecular weight 506.27 Da
    AlogP 4.93692
    HBond acceptors 8
    HBond donors 1
    Atoms 69

    Vendors

    Note: This is not an exhaustive list and does not indicate endorsement by the portal.

    Expert Reviews


    (on 22 Jun 2023)
    Cellular Use Rating
    In Model Organisms
    This probe is of high quality and has good selectivity for its target. However, at concentrations below the recommended there are issues with in-family selectivity which may make making conclusions more...
    (on 17 Jul 2023)
    Cellular Use Rating
    In Model Organisms
    Abemaciclib is a potent inhibitor of many CDKs as well as many CMGC family member such as DYRK1A and HIP kinases. It would be not be possible to assign a function in cells to CDK4/6 based on Abemaciclib...
    Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria